Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05276674 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ZNN Bactiguard Retrograde Femoral Nails PMCF Study

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Site details revised at 1 of 4 sitesv8
  2. Notable Primary and study completion dates: Nov 2026 to Dec 2027v7
  3. Minor Study sites: 1 to 4v6
  4. Notable Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Primary and study completion dates: Aug 2026 to Nov 2026 · Start date changed from estimate of Aug 2023 to Oct 23, 2023v5 Show 3 more changesShow less
    • Study sites: 0 to 1
    • Primary and study completion dates: Aug 2026 to Nov 2026
    • Start date changed from estimate of Aug 2023 to Oct 23, 2023
  5. Notable Start date: Apr 2023 to Aug 2023 Primary and study completion dates: Apr 2026 to Aug 2026v4 Show 1 more changeShow less
    • Primary and study completion dates: Apr 2026 to Aug 2026
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Start date: Dec 2022 to Apr 2023 Primary and study completion dates: Dec 2025 to Apr 2026v3 Show 1 more changeShow less
    • Primary and study completion dates: Dec 2025 to Apr 2026
  2. Notable Start date: Jun 2022 to Dec 2022 Primary and study completion dates: Jun 2025 to Dec 2025 · Eligibility criteria expanded, about 6 words · Secondary endpoints: details revised at 2 of 4 entriesv2 Show 3 more changesShow less
    • Primary and study completion dates: Jun 2025 to Dec 2025
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 2 of 4 entries

    See this version in full on ClinicalTrials.gov ↗

  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
83 trials monitored
See 1 trial at risk
Post-market clinical follow-up (PMCF) study to confirm the safety, performance, and clinical benefits of the intra-medullary retrograde femoral nail Zimmer Natural Nail (ZNN) Bactiguard (implants and instrumentation) when used for the temporary internal fixation and stabilization of femoral fractures.
Trial Details
NCT Number NCT05276674
Lead Sponsor Zimmer Biomet
Conditions Femoral Fracture
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov